ANAB – anaptysbio, inc. (US:NASDAQ)
Stock Stats
News
AnaptysBio (ANAB) had its price target raised by Stifel Nicolaus from $56.00 to $85.00. They now have a "buy" rating on the stock.
AnaptysBio Details Plan to Split Into RoyaltyCo and Biopharma at TD Cowen Healthcare Conference [Yahoo! Finance]
AnaptysBio (ANAB) had its price target raised by Barclays PLC from $78.00 to $79.00. They now have an "overweight" rating on the stock.
AnaptysBio (ANAB) had its price target raised by HC Wainwright from $51.00 to $66.00. They now have a "buy" rating on the stock.
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Form 10-K ANAPTYSBIO, INC For: Dec 31
Form 8-K ANAPTYSBIO, INC For: Mar 03
Form 4 ANAPTYSBIO, INC For: Feb 11 Filed by: LOUMEAU ERIC J
Form 144 ANAPTYSBIO, INC Filed by: LOUMEAU ERIC J
Form SCHEDULE 13G/A ANAPTYSBIO, INC Filed by: MORGAN STANLEY
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.